Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark
Kåre Mølbak(Statens Serum Institut), S Glismann(Statens Serum Institut), A Mazick(Statens Serum Institut), Palle Valentiner‐Branth(Statens Serum Institut), Katarina Widgren(Statens Serum Institut), Lars Peter Nielsen(MACOM (United States)), Tyra Grove Krause(Statens Serum Institut), A H Christiansen(Statens Serum Institut), K. Jensen(Statens Serum Institut), Katja Majlund Harder(Statens Serum Institut), Sophie Gubbels(Statens Serum Institut), Jens Nielsen(Statens Serum Institut), Hanne‐Dorthe Emborg(Statens Serum Institut), Peter Henrik Andersen(Statens Serum Institut), Steen Ethelberg(Statens Serum Institut)
Cited by 30
Related Papers
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
<i>Salmonella</i>Control Programs in Denmark
|Emerging infectious diseases|2003|343
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280